Literature DB >> 24568494

Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.

Xiao-Yan Cai1, Jia-Xing Wang, Yong Yi, Hong-Wei He, Xiao-Chun Ni, Jian Zhou, Yun-Feng Cheng, Jian-Jun Jin, Jia Fan, Shuang-Jian Qiu.   

Abstract

OBJECTIVES: TCR- gamma-delta + T cells (γδ T cells) are non-conventional T lymphocytes that can recognize and eradicate tumor cells. Our previous studies showed that infiltration and function of γδT cells were substantially attenuated in hepatocellular carcinoma (HCC). However, their prognostic value was not clarified.
METHODS: The association between γδ T cells and the clinical outcomes was determined by immunohistochemistry (IHC) in a HCC patient cohort (n = 342).
RESULTS: Immunohistochemistry showed decreased infiltration of γδ T cells in tumoral tissues compared with paired peritumoral tissues. The counts of γδ T cells in peritumoral tissues were negatively correlated with tumor size (P = 0.005). Survival analysis showed that the levels of peritumoral γδ T cells were related to both time to recurrence (TTR) and overall survival (OS) (P = 0.010 and P = 0.036, respectively) in univariate analysis, and related to TTR in multivariate analysis (P = 0.014, H.R. [95% CI] = 0.682 [0.502-0.927]). Furthermore, the level of peritumoral γδ T cells showed independent prognostic value for TTR in Barcelona Clinic Liver Cancer (BCLC) stage A patients (P = 0.038, H.R. [95% CI] = 0.727 [0.537-0.984]). However, tumoral γδ T cells did not show independent prognostic value for either TTR or OS in HCC patients.
CONCLUSIONS: Low counts of γδ T cells in peritumoral liver tissue are related to a higher incidence of recurrence in HCC and can predict postoperative recurrence, especially in those with early-stage HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24568494     DOI: 10.7314/apjcp.2014.15.2.775

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer.

Authors:  Jieti Wang; Chao Lin; He Li; Ruochen Li; Yifan Wu; Hao Liu; Heng Zhang; Hongyong He; Weijuan Zhang; Jiejie Xu
Journal:  Oncoimmunology       Date:  2017-07-24       Impact factor: 8.110

Review 2.  γδ T cells in liver diseases.

Authors:  Xuefu Wang; Zhigang Tian
Journal:  Front Med       Date:  2018-02-14       Impact factor: 4.592

3.  Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages.

Authors:  Moulay Yassine Belghali; Brahim Admou; Maroua Brahimi; Mouna Khouchani; Saadia Ba-M'hamed
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

4.  High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity.

Authors:  Xiuli Jin; Shuairan Zhang; Ningning Wang; Lin Guan; Chuanli Shao; Yingbo Lin; Jianping Liu; Yiling Li
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

Review 5.  Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.

Authors:  Benjamin Ruf; Bernd Heinrich; Tim F Greten
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

6.  Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.

Authors:  Na Zhao; Hien Dang; Lichun Ma; Sean P Martin; Marshonna Forgues; Kris Ylaya; Stephen M Hewitt; Xin Wei Wang
Journal:  Hepatology       Date:  2021-03       Impact factor: 17.298

7.  Liver-infiltrating CD11b-CD27- NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression.

Authors:  Qiong-Fang Zhang; Wen-Wei Yin; Yang Xia; Ya-Yang Yi; Qiu-Feng He; Xing Wang; Hong Ren; Da-Zhi Zhang
Journal:  Cell Mol Immunol       Date:  2016-06-20       Impact factor: 11.530

8.  Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma.

Authors:  Ze-Long Liu; Ling-Ling Zhu; Jing-Hua Liu; Zhang-Ya Pu; Zhi-Ping Ruan; Jiang Chen
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

Review 9.  Cancer immunotherapy with γδ T cells: many paths ahead of us.

Authors:  Dieter Kabelitz; Ruben Serrano; Léonce Kouakanou; Christian Peters; Shirin Kalyan
Journal:  Cell Mol Immunol       Date:  2020-07-22       Impact factor: 11.530

10.  High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.

Authors:  Huanzi Lu; Wenxiao Dai; Junyi Guo; Dikan Wang; Shuqiong Wen; Lisa Yang; Dongjia Lin; Wenqiang Xie; Liling Wen; Juan Fang; Zhi Wang
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.